Your brain can change. Here's what that actually means.
Your brain can change... Here's what that actually means.
For decades, we assumed the adult brain was essentially fixed. You were born with a certain number of neurons, they wired themselves up during childhood and adolescence, and after that the structure was largely set. Mental illness, under this framework, was a malfunction in a static system, something to be managed, not fundamentally changed.
That framework was wrong.
What decades of neuroscience research have now established is that the adult brain retains a remarkable capacity for structural and functional change throughout life. Neurons form new connections. Existing connections strengthen or weaken based on activity. Circuits that have gone quiet can be reactivated. Patterns of communication that have become disordered can be reorganized.
This capacity is called neuroplasticity. And it is the foundational concept behind everything we do at Optimal TMS.
What neuroplasticity actually is
What goes wrong in depression
Why TMS targets neuroplasticity directly
Why accelerated protocols leverage neuroplasticity more effectively
What this means for patients
What neuroplasticity actually is
Neuroplasticity isn't one thing, instead it's a category of processes, all of which describe ways the brain reorganizes itself in response to experience, activity, or intervention.
The most clinically relevant forms for understanding TMS are:
Synaptic plasticity is the strengthening or weakening of connections between individual neurons. When two neurons fire together repeatedly, the synapse between them strengthens. This is the cellular basis of learning and memory, and it's captured in the phrase often attributed to neuroscientist Donald Hebb: "neurons that fire together, wire together."
Dendritic spine remodeling, dendritic spines are the tiny protrusions on neurons where synaptic connections form. Their density and shape reflect the health of a neuron's connectivity. Chronic stress causes dendritic spine loss in the prefrontal cortex, physically reducing the number of active connections. Effective antidepressant treatments, including TMS, can restore lost spines. A study published in Science in 2019 demonstrated that sustained antidepressant effects required this kind of structural spine restoration, not just temporary changes in neural firing.
Long-term potentiation (LTP) is a process by which repeated stimulation of a synapse produces a lasting increase in that synapse's strength. LTP is widely considered the primary cellular mechanism behind learning, memory, and the durable effects of brain stimulation therapies. TMS protocols are specifically designed to induce LTP in targeted cortical regions.
Neurogenesis is the birth of new neurons, which continues in certain brain regions throughout adulthood, including the hippocampus. Chronic stress suppresses neurogenesis. Many effective antidepressant treatments promote it.
What goes wrong in depression
Depression is not simply a serotonin deficiency. That model is sometimes called the monoamine hypothesis, explains why SSRIs work for some patients, but it doesn't explain why they don't work for many others, why response takes weeks even when it works, or why TMS produces antidepressant effects through an entirely different mechanism.
A more complete picture involves neuroplasticity disruption. Chronic stress is one of the most robust triggers of depression and produces measurable structural changes in the brain. The prefrontal cortex, which is responsible for regulating mood, motivation, decision-making, and emotional response, shows reduced activity and physical deterioration of neural connections under chronic stress. Dendritic spines are lost. Synaptic connections weaken. The circuits that normally allow the prefrontal cortex to regulate the brain's threat and emotional systems, particularly the amygdala become dysregulated.
The result isn't just a feeling of sadness. It's a pattern of disrupted circuit communication that manifests as the full constellation of depressive symptoms: reduced motivation, anhedonia, impaired decision-making, difficulty regulating emotional responses, and a brain that has lost some of its structural capacity for change.
This matters because it reframes the treatment question. If depression involves structural circuit disruption, the goal of treatment isn't just to alter neurochemistry , it's to restore the brain's capacity to reorganize. That's a neuroplasticity problem. And neuroplasticity requires more than a daily pill.
Why TMS targets neuroplasticity directly
Transcranial magnetic stimulation works by delivering focused magnetic pulses to specific cortical regions, inducing electrical activity in the neurons beneath the coil. When those neurons fire repeatedly session after session the synaptic connections between them begin to strengthen through LTP-like mechanisms.
But TMS doesn't just stimulate neurons. It creates the conditions for neuroplasticity to occur. The distinction matters. A single TMS session produces transient changes in cortical excitability. A full course of TMS, particularly an accelerated course with multiple sessions per day, produces lasting structural changes: restored dendritic spines, strengthened synaptic connections, and reorganized circuit dynamics that persist long after the last session is complete.
This is why TMS response is gradual even when the treatment itself is rapid. The brain isn't responding to a drug that's present in the system. It's undergoing structural rewiring, a process that takes time to consolidate even when the stimulus driving that rewiring is complete.
A landmark study published in Science in 2022 showed that ketamine's antidepressant effects required the formation of new dendritic spines in the prefrontal cortex and that blocking spine formation blocked the antidepressant effect. The same structural logic applies to TMS. The treatment opens a neuroplasticity window. The brain does the actual rebuilding. What happens in that window behavioral activation, therapy, sleep, and exercise determine how completely the brain takes advantage of it.
Why accelerated protocols leverage neuroplasticity more effectively
Traditional once-daily TMS delivers one session per day, five days per week, for six weeks. Each session stimulates the target region and induces some degree of synaptic potentiation. But the 23 hours between sessions allow that potentiation signal to dissipate before the next session reinforces it.
Accelerated protocols, like the five-day intensive modeled after the Stanford SAINT protocol or the single-day intensive modeled after the ONE-D study, deliver multiple sessions per day with precisely timed intervals between them, typically 30 to 60 minutes. This timing is not arbitrary. Each session opens a neuroplasticity window, a period of heightened synaptic responsiveness during which the next session's effects compound on the previous one rather than starting from baseline.
The result is a fundamentally different biological dose, not merely a faster accumulation of the same dose. This is likely why published remission rates for accelerated protocols are substantially higher than those for traditional once-daily TMS, despite delivering the same total pulse count in a fraction of the time.
A preclinical study published in Cell in 2026 by researchers at UCLA added important mechanistic detail to this picture. Using a mouse model of the accelerated iTBS protocol the same stimulation pattern used in the SAINT-based five-day protocol the researchers identified that TMS selectively activates a specific class of prefrontal neurons called intratelencephalic (IT) neurons. These neurons showed persistently elevated activity during stimulation and recovered stress-induced dendritic spine loss. When IT neurons were silenced during TMS, the antidepressant behavioral effects disappeared entirely. This was the first study to causally link a specific neural cell type to TMS's therapeutic mechanism and it directly supports the neuroplasticity framework at the center of accelerated TMS.
It's worth being clear: this was a rodent study. Its findings cannot be directly translated to human clinical outcomes, and the authors themselves note that clinical implications must be interpreted conservatively. But it represents meaningful mechanistic validation of why accelerated iTBS works the way it does and it's consistent with what clinical trials have shown at the outcome level.
What this means for patients
Understanding neuroplasticity changes how you think about TMS treatment in two important ways.
First, it reframes the timeline. TMS doesn't work like a painkiller. You don't feel it working while it's happening, and you don't get the full effect the day after your last session. The brain is consolidating structural changes over weeks. The peak of response for most patients comes four to six weeks after treatment, even when the treatment itself was completed in one or five days. Expecting results on day two sets you up for discouragement that the biology doesn't warrant.
Second, it makes what you do during and after treatment matter. The neuroplasticity window TMS creates is an opportunity, not a guarantee. Behavioral activation, therapy, quality sleep, regular exercise, and minimizing alcohol all support the consolidation of neuroplastic changes. Passive waiting does not. The patients who get the most out of TMS are typically the ones who treat the post-treatment window as something to actively engage with, not simply wait through.
At Optimal TMS, patient education about neuroplasticity isn't background information. It's part of the treatment. Our lead provider's doctoral research demonstrated that patients who understand what is happening in their brain and why achieve measurably better outcomes than patients who don't. This article is an example of that philosophy in practice.
Sources:
